• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

米诺地尔对正常人角质形成细胞增殖和分化的双相作用。

Biphasic effects of minoxidil on the proliferation and differentiation of normal human keratinocytes.

作者信息

Boyera N, Galey I, Bernard B A

机构信息

L'Oréal, Hair Biology Research Group, Clichy, France.

出版信息

Skin Pharmacol. 1997;10(4):206-20. doi: 10.1159/000211506.

DOI:10.1159/000211506
PMID:9413895
Abstract

Minoxidil is the most used drug with proved effects in the treatment of androgenetic alopecia (AGA), but little is known about its pharmacological activity and target cells in hair follicles. As AGA is characterized by follicle atrophy, accelerated hair cycles and hair fiber thinning, we postulated that keratinocyte proliferation/differentiation is affected and we tested Minoxidil's effects on those parameters. Normal human keratinocytes (NHK) of follicular or epidermal origin were cultured in the presence of Minoxidil (0, 0.1, 1, 10, 100, 1,000 microM) during 5-8 days in various media (high-/low-calcium content, with or without serum). Proliferation was assessed by mitochondrial dehydrogenase activity (XTT), BrdU incorporation, lysosome numeration (neutral red incorporation) and total protein dosage. Drug-induced cytotoxicity was measured by lactate dehydrogenase release in culture supernatant, and pro-differentiating effects were evaluated by relative involucrin expression (ELISA dosage). On this basis, we showed that Minoxidil had biphasic effects on the proliferation and differentiation of NHK: Minoxidil stimulated NHK proliferation at micromolar doses, while antiproliferative, pro-differentiative and partially cytotoxic effects were observed with millimolar concentrations. We can hypothesize that Minoxidil hypertrichotic activity in vivo is possibly mediated by the maintenance of proliferative potential in follicular keratinocytes precociously committed to differentiation.

摘要

米诺地尔是治疗雄激素性脱发(AGA)最常用且已证实有效的药物,但对其药理活性及毛囊中的靶细胞却知之甚少。由于AGA的特征是毛囊萎缩、毛囊周期加速和毛发纤维变细,我们推测角质形成细胞的增殖/分化受到影响,并测试了米诺地尔对这些参数的作用。将来源于毛囊或表皮的正常人角质形成细胞(NHK)在不同培养基(高/低钙含量、含或不含血清)中,于米诺地尔(0、0.1、1、10、100、1000微摩尔)存在的情况下培养5 - 8天。通过线粒体脱氢酶活性(XTT)、BrdU掺入、溶酶体计数(中性红掺入)和总蛋白定量来评估增殖情况。通过测量培养上清液中乳酸脱氢酶的释放来检测药物诱导的细胞毒性,并通过相对内披蛋白表达(ELISA定量)来评估促分化作用。在此基础上,我们表明米诺地尔对NHK的增殖和分化具有双相作用:米诺地尔在微摩尔剂量下刺激NHK增殖,而在毫摩尔浓度下观察到抗增殖、促分化和部分细胞毒性作用。我们可以推测,米诺地尔在体内的多毛活性可能是由维持过早进入分化阶段的毛囊角质形成细胞的增殖潜能介导的。

相似文献

1
Biphasic effects of minoxidil on the proliferation and differentiation of normal human keratinocytes.米诺地尔对正常人角质形成细胞增殖和分化的双相作用。
Skin Pharmacol. 1997;10(4):206-20. doi: 10.1159/000211506.
2
Minoxidil stimulates mouse vibrissae follicles in organ culture.米诺地尔在器官培养中刺激小鼠触须毛囊。
J Invest Dermatol. 1989 Mar;92(3):315-20. doi: 10.1111/1523-1747.ep12277095.
3
Effects of hypertrichotic agents on follicular and nonfollicular cells in vitro.多毛症药物对体外毛囊细胞和非毛囊细胞的影响。
Skin Pharmacol. 1996;9(1):3-8. doi: 10.1159/000211384.
4
Minoxidil: inhibition of proliferation of keratinocytes in vitro.米诺地尔:体外对角质形成细胞增殖的抑制作用。
J Invest Dermatol. 1991 Sep;97(3):534-6. doi: 10.1111/1523-1747.ep12481560.
5
Effect of minoxidil on proliferation and apoptosis in dermal papilla cells of human hair follicle.米诺地尔对人毛囊真皮乳头细胞增殖和凋亡的影响。
J Dermatol Sci. 2004 Apr;34(2):91-8. doi: 10.1016/j.jdermsci.2004.01.002.
6
Effect of minoxidil on pre- and postconfluent keratinocytes.米诺地尔对融合前和融合后角质形成细胞的作用。
J Am Acad Dermatol. 1987 Mar;16(3 Pt 2):648-52. doi: 10.1016/s0190-9622(87)70082-6.
7
The additive effects of minoxidil and retinol on human hair growth in vitro.米诺地尔和视黄醇对体外人毛发生长的相加作用。
Biol Pharm Bull. 2007 Jan;30(1):21-6. doi: 10.1248/bpb.30.21.
8
Minoxidil Acts as an Antiandrogen: A Study of 5α-reductase Type 2 Gene Expression in a Human Keratinocyte Cell Line.米诺地尔具有抗雄激素作用:人角质形成细胞系中2型5α-还原酶基因表达的研究
Acta Dermatovenerol Croat. 2017 Dec;25(4):271-275.
9
Effects of cepharanthine and minoxidil on proliferation, differentiation and keratinization of cultured cells from the murine hair apparatus.千金藤素和米诺地尔对小鼠毛囊器官培养细胞增殖、分化和角质化的影响。
Arch Dermatol Res. 1992;284(5):290-6. doi: 10.1007/BF00372583.
10
Potassium channel openers stimulate DNA synthesis in mouse epidermal keratinocyte and whole hair follicle cultures.
Skin Pharmacol. 1993;6(3):170-8. doi: 10.1159/000211131.

引用本文的文献

1
Topical dutasteride for androgenic alopecia: current state and prospects.外用度他雄胺治疗雄激素性脱发:现状与前景
Ther Deliv. 2025 Mar;16(3):271-283. doi: 10.1080/20415990.2024.2437973. Epub 2024 Dec 6.
2
Manifestation of pityriasis amiantacea following initiation of minoxidil.米诺地尔开始使用后石棉状糠疹的表现。
JAAD Case Rep. 2022 Apr 13;24:94-96. doi: 10.1016/j.jdcr.2022.04.002. eCollection 2022 Jun.
3
Hair Growth Activity of Three Plants of the Polynesian Cosmetopoeia and Their Regulatory Effect on Dermal Papilla Cells.
三种波利尼西亚化妆品植物的毛发生长活性及其对真皮乳头细胞的调节作用。
Molecules. 2020 Sep 23;25(19):4360. doi: 10.3390/molecules25194360.
4
Minoxidil is a potential neuroprotective drug for paclitaxel-induced peripheral neuropathy.米诺地尔是一种潜在的神经保护药物,可用于紫杉醇诱导的周围神经病。
Sci Rep. 2017 Mar 28;7:45366. doi: 10.1038/srep45366.
5
Hair growth-promoting effect of Geranium sibiricum extract in human dermal papilla cells and C57BL/6 mice.老鹳草提取物对人毛乳头细胞和C57BL/6小鼠的促毛发生长作用
BMC Complement Altern Med. 2017 Feb 13;17(1):109. doi: 10.1186/s12906-017-1624-4.
6
Hormesis and medicine.毒物兴奋效应与医学
Br J Clin Pharmacol. 2008 Nov;66(5):594-617. doi: 10.1111/j.1365-2125.2008.03243.x. Epub 2008 Jun 28.
7
Hormesis [biological effects of low level exposures (BELLE)] and dermatology.低水平暴露(BELLE)的生物学效应与皮肤病学。
Dose Response. 2008 Feb 1;6(1):1-15. doi: 10.2203/dose-response.07-029.Thong.
8
Promotive effect of minoxidil combined with all-trans retinoic acid (tretinoin) on human hair growth in vitro.米诺地尔联合全反式维甲酸(维甲酸)对人毛发生长的体外促进作用。
J Korean Med Sci. 2007 Apr;22(2):283-9. doi: 10.3346/jkms.2007.22.2.283.